Cargando…

Patient-derived breast tumor xenografts facilitating personalized cancer therapy

Despite improved detection and reduction of breast cancer-related deaths over the recent decade, breast cancer remains the second leading cause of cancer death for women in the US, with 39,510 women expected to succumb to metastatic disease in 2012 alone (American Cancer Society, Cancer Facts &F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landis, Melissa D, Lehmann, Brian D, Pietenpol, Jennifer A, Chang, Jenny C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672825/ https://www.ncbi.nlm.nih.gov/pubmed/23339383 http://dx.doi.org/10.1186/bcr3355

Ejemplares similares

Cultured circulating tumor cells and their derived xenografts for personalized oncology
por: Wang, Ruoxiang, et al.
Publicado: (2016)

Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model
por: Dave, Bhuvanesh, et al.
Publicado: (2012)

Correction: Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model
por: Dave, Bhuvanesh, et al.
Publicado: (2012)

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
por: Chen, Xi, et al.
Publicado: (2012)

Clinically relevant inflammatory breast cancer patient-derived xenograft–derived ex vivo model for evaluation of tumor-specific therapies
por: Eckhardt, Bedrich L., et al.
Publicado: (2018)

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
por: Goetz, Matthew P., et al.
Publicado: (2017)

Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models
por: Rosato, Roberto R., et al.
Publicado: (2018)

Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
por: Patrizii, Michele, et al.
Publicado: (2018)

Phenformin as prophylaxis and therapy in breast cancer xenografts
por: Appleyard, M V C L, et al.
Publicado: (2012)

Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts
por: Ntai, Ioanna, et al.
Publicado: (2016)

Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer
por: Jovanović, Bojana, et al.
Publicado: (2014)

Syk: a new player in the field of breast cancer
por: Stewart, Zoe A, et al.
Publicado: (2001)

RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
por: Bauer, Joshua A, et al.
Publicado: (2010)

Molecular profiling of patient-derived breast cancer xenografts
por: Reyal, Fabien, et al.
Publicado: (2012)

Patient-Derived Xenograft Models of Breast Cancer and Their Application
por: Murayama, Takahiko, et al.
Publicado: (2019)

Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts
por: Morancho, Beatriz, et al.
Publicado: (2016)

Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancer
por: Butti, Ramesh, et al.
Publicado: (2023)

Establishing a colorectal cancer liver metastasis patient-derived tumor xenograft model for the evaluation of personalized chemotherapy
por: Jung, Joohee, et al.
Publicado: (2017)

Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer
por: Matossian, Margarite D., et al.
Publicado: (2020)

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
por: Ring, Brian Z., et al.
Publicado: (2016)

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
por: Lehmann, Brian D., et al.
Publicado: (2016)

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
por: Ring, Brian Z., et al.
Publicado: (2016)

Patient-derived xenograft models of breast cancer and their predictive power
por: Whittle, James R, et al.
Publicado: (2015)

Patient-derived tumour xenografts for breast cancer drug discovery
por: Cassidy, John W, et al.
Publicado: (2016)

Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts
por: Chen, Di, et al.
Publicado: (2007)

Applications of patient-derived tumor xenograft models and tumor organoids
por: Yoshida, Go J.
Publicado: (2020)

Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases
por: Contreras-Zárate, María J., et al.
Publicado: (2017)

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
por: Pu, Xingxiang, et al.
Publicado: (2018)

Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors
por: Savage, Paul, et al.
Publicado: (2020)

Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models
por: Sprouffske, Kathleen, et al.
Publicado: (2020)

Susan G. Komen Big Data for Breast Cancer Initiative: How Patient Advocacy Organizations Can Facilitate Using Big Data to Improve Patient Outcomes
por: Jourquin, Jerome, et al.
Publicado: (2019)

Patient-derived cell line, xenograft and organoid models in lung cancer therapy
por: Huo, Ku-Geng, et al.
Publicado: (2020)

Orthotopic Patient-Derived Xenografts of Pediatric Solid Tumors
por: Stewart, Elizabeth, et al.
Publicado: (2017)

Patient-derived xenograft models in cancer therapy: technologies and applications
por: Liu, Yihan, et al.
Publicado: (2023)

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
por: Grinde, Maria T, et al.
Publicado: (2014)

Selumetinib-based therapy in uveal melanoma patient-derived xenografts
por: Decaudin, Didier, et al.
Publicado: (2018)

Patient-derived xenograft (PDX) tumors increase growth rate with time
por: Pearson, Alexander T., et al.
Publicado: (2016)

Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts
por: McCord, Matthew, et al.
Publicado: (2022)

Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts
por: Leiting, Jennifer L., et al.
Publicado: (2019)

Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors()
por: Bondarenko, Gennadiy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ff4chg6rv0vjh5jqahsagpppbe